Bravida (BRAV) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
1 Jun, 2026Executive summary
Net sales for Q3 2024 were SEK 6,575 million, flat year-over-year, with service sales up 8% and installation sales down 7%.
EBITA margin declined to 4.5% from 5.4%, mainly due to operational challenges and SEK 19 million in restructuring costs in Denmark and southern Sweden.
Strong operating cash flow of SEK 193 million, with cash conversion improving to 134%.
Order intake declined 12% year-over-year, but order backlog remains high with healthy margins, except in Denmark where backlog increased.
LTIFR improved by 17% year-over-year, and profit after tax was SEK 200 million, down from SEK 251 million.
Financial highlights
Net sales for Jan–Sep 2024 rose 1% to SEK 21,545 million, with organic growth at -3% and acquisitions contributing 5%.
EBITA for Jan–Sep 2024 fell 18% to SEK 930 million, with a margin of 4.3%.
Basic and diluted EPS for Q3 were SEK 0.96 (down 21%), and SEK 3.10 for Jan–Sep (down 22%).
Net debt/EBITDA improved to 1.2x, and cash conversion reached 134% (up from 57%).
Equity/assets ratio was 33.0% at quarter-end.
Outlook and guidance
Service demand remains stable, but installation volumes are pressured by a weak construction market, especially in southern Sweden and Finland.
Management expects continued weak demand through the rest of 2024 and into H1 2025, with improvement anticipated in late H1 or H2 2025.
Margin target of 7% remains for 2026; 2025 will be a transformation year with focus on margin over volume, cost control, and selective project intake.
Attractive pipeline for acquisitions remains.
Latest events from Bravida
- EBITA/EBITDA margin rose to 5.3% as Denmark outperformed, offsetting weak sales and markets.BRAV
Q3 202529 May 2026 - Net sales and EBITA rose, order backlog strengthened, and a SEK 100m share buyback was launched.BRAV
Q1 20265 May 2026 - EBITA margin and EPS rose in Q4, with strong cash flow and a higher dividend proposed.BRAV
Q4 202511 Apr 2026 - Flat sales, improved margins, strong cash flow, and higher dividend despite market headwinds.BRAV
Q4 202418 Feb 2026 - Q2 sales up 5%, margin down to 4.5%, but cash flow and backlog strong; margin recovery expected.BRAV
Q2 20243 Feb 2026 - EBITA margin rose to 4.5% as profit grew despite lower sales and market uncertainty.BRAV
Q1 202517 Nov 2025 - EBITA margin rose to 5.4% and order intake increased 9% despite a 9% sales decline.BRAV
Q2 202513 Nov 2025